MEGAN BRECHER: Open Payments
NPI 1437651965 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 32 payments from 16 companies in 2025. Trend: 2023 $191 · 2024 $298 · 2025 $940
Food & beverage: $741Education: $199
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $215 |
| Merck Sharp & Dohme LLC | 5 | $133 |
| Incyte Corporation | 4 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 2 | $64 |
| Janssen Biotech, Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
Products named: KEYTRUDA, JAKAFI, Nubeqa, OJJAARA, LIBTAYO, ERLEADA, POTELIGEO, DATROWAY.
Industry payments across FL — which companies pay providers there.
